Valtrex revenues declined 34% following the entry of generic competition in November 2009. Pharmaceuticals sales for the year were boosted by strong ...
In terms of 2010, clearly in 2010, we are going to be adversely impacted by Valtrex generics, and we're expecting a margin of around, a cost of goods margin ...
While Ranbaxy is expected to post a strong set of numbers on the back of its Valtrex launch, Dr Reddy's is expected to report a decline on a slowdown in ...
Email this story